Clinical Drug Investigation

Journal Title：Clinical Drug Investigation

Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:

-Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.

-Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.

-Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.

-Studies focusing on the application of drug delivery technology in healthcare.

-Short communications and case study reports that meet the above criteria will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.

《临床药物调查》提供快速发表原创研究成果的服务，涵盖临床药物开发和药物治疗用途的所有阶段。该期刊包括：

-临床试验、结果研究、临床药物经济学研究和药物流行病学研究，与一种或一组药物的最佳处方实践密切相关。

-临床药效学和临床药代动力学研究，与临床实践密切相关。

-健康志愿者的药效学和药代动力学研究，其中讨论了对临床处方的重要影响。

-专注于药物输送技术在医疗保健中的应用的研究。

-符合上述标准的简短通讯和案例研究报告也将被考虑。

其他数字功能（包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画）可以与文章一起发布；这些旨在提高期刊内容的知名度、读者群和教育价值。此外，在《临床药物调查》上发表的文章可能附有通俗易懂的摘要，以帮助对该领域有一定了解但缺乏深入专业知识的读者了解重要的医学进展。

Clinical Drug Investigation创刊于1989年，由Springer International Publishing出版商出版，收稿方向涵盖医学 - 药学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 较慢,6-12周 ，影响因子指数2.9，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。